TLL018-205 Enrolling

Plaque Psoriasis Clinical Trial – Moderate-to-Severe (4 Months)

Treatment: Oral Age: 18 - 75 Years

Recruiting adults 18-75 years of age with a diagnosis of plaque psoriasis for a clinical trial. Eligible candidates must have a diagnosis of moderate-to-severe plaque psoriasis covering 10% or more of their body surface area (BSA) for the past 6 months or more, but not other forms of psoriasis.  A body mass index (BMI) of 18.0 – 35.0 kg/m2 is also required. Participants who have not received systemic treatment for plaque psoriasis, or who have received at least one conventional anti-psoriasis treatment, may be eligible to participate.

Participants will receive investigational oral treatment (active study drug) or placebo during the treatment period. Study treatment and study-related assessments will be provided at no cost.  Reimbursement for study-related expenses may be provided.

Study participation will last about 4 months and involve about 8 visits to the study centre.

The following information is from

Last Update Posted: March 01, 2023

Study Description

  • Ages Eligible for Study:

    18-75 Years

  • Sexes Eligible for Study:

    Male and Female

Terms and Conditions –
Purpose of Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed to provide patients, family members, and members of the public current information about clinical research studies.

Participating Locations

United States

Participating Experts

Dr. James Wang


You May Also Be Interested In

Similar Trials

No Similar Trials Found

Learn More About


Learn More
2022 all rights reserved probity medical research inc
find a trial
filter trials